MyFinsight
Home
Blog
About
Metabolic
$219,067K
(48.15%↑ Y/Y)
Oncology
$209,372K
(11.04%↑ Y/Y)
Other
$98,279K
(-16.76%↓ Y/Y)
Central Nervous System
$82,858K
Cardiology
$59,982K
(2.39%↑ Y/Y)
Antiviral And Anti
Infective
$37,773K
(29.78%↑ Y/Y)
Revenue, net (includes
4.7 million and 16.9...
$707,331K
(17.24%↑ Y/Y)
Interest income, net
$4,986K
(362.52%↑ Y/Y)
Income from operations
$146,824K
(16.22%↑ Y/Y)
Total other income
(expense), net
$4,839K
(369.28%↑ Y/Y)
Total operating
expenses
$560,507K
(17.51%↑ Y/Y)
Miscellaneous (expense)
income, net
-$147K
(94.89%↑ Y/Y)
Income before income
taxes
$151,663K
(21.78%↑ Y/Y)
Total direct costs
$505,694K
(19.47%↑ Y/Y)
Selling, general and
administrative
$48,103K
(3.08%↑ Y/Y)
Depreciation
$6,555K
(-3.28%↓ Y/Y)
Amortization
$155K
(-34.60%↓ Y/Y)
Net income
$121,362K
(34.46%↑ Y/Y)
Income tax provision
$30,301K
(-11.60%↓ Y/Y)
Reimbursable Out Of Pocket
Costs
$303,139K
(27.65%↑ Y/Y)
Direct Costs
$202,555K
(9.00%↑ Y/Y)
Back
Back
Income Statement
Medpace Holdings, Inc. (MEDP)
Medpace Holdings, Inc. (MEDP)
source: myfinsight.com